Free Trial

GC Wealth Management RIA LLC Invests $6.75 Million in Synopsys, Inc. $SNPS

Synopsys logo with Computer and Technology background

Key Points

  • GC Wealth Management RIA LLC invested approximately $6.75 million in Synopsys, Inc., purchasing 13,171 shares during the second quarter.
  • Analysts have recently downgraded Synopsys with multiple price target reductions, leading to a consensus target price of $585.33 amidst varying ratings of buy, hold, and sell.
  • Insider activity showed mixed signals, with Director Robert Painter buying 350 shares while CFO Shelagh Glaser sold 3,655 shares, indicating fluctuations in insider confidence.
  • MarketBeat previews top five stocks to own in October.

GC Wealth Management RIA LLC bought a new position in Synopsys, Inc. (NASDAQ:SNPS - Free Report) during the second quarter, according to its most recent disclosure with the SEC. The firm bought 13,171 shares of the semiconductor company's stock, valued at approximately $6,753,000.

Several other hedge funds have also bought and sold shares of SNPS. Independence Bank of Kentucky increased its holdings in Synopsys by 120.0% in the 2nd quarter. Independence Bank of Kentucky now owns 55 shares of the semiconductor company's stock worth $28,000 after acquiring an additional 30 shares in the last quarter. Cornerstone Planning Group LLC raised its position in shares of Synopsys by 275.0% during the 1st quarter. Cornerstone Planning Group LLC now owns 60 shares of the semiconductor company's stock valued at $25,000 after purchasing an additional 44 shares during the period. Saudi Central Bank purchased a new position in shares of Synopsys during the 1st quarter valued at $26,000. Clal Insurance Enterprises Holdings Ltd boosted its holdings in Synopsys by 441.7% in the 1st quarter. Clal Insurance Enterprises Holdings Ltd now owns 65 shares of the semiconductor company's stock worth $28,000 after buying an additional 53 shares during the period. Finally, WPG Advisers LLC bought a new position in Synopsys in the 1st quarter worth $34,000. Institutional investors own 85.47% of the company's stock.

Analyst Upgrades and Downgrades

A number of research firms have commented on SNPS. KeyCorp decreased their price target on Synopsys from $660.00 to $590.00 and set an "overweight" rating on the stock in a report on Wednesday, September 10th. Zacks Research downgraded Synopsys from a "hold" rating to a "strong sell" rating in a research note on Friday, September 12th. Rosenblatt Securities reissued a "neutral" rating and issued a $605.00 price target (down from $650.00) on shares of Synopsys in a report on Wednesday, September 10th. Needham & Company LLC cut their price objective on shares of Synopsys from $660.00 to $550.00 and set a "buy" rating for the company in a report on Wednesday, September 10th. Finally, Baird R W downgraded shares of Synopsys from a "strong-buy" rating to a "hold" rating in a report on Wednesday, September 10th. Eleven investment analysts have rated the stock with a Buy rating, four have assigned a Hold rating and three have given a Sell rating to the company's stock. According to data from MarketBeat, Synopsys currently has an average rating of "Hold" and a consensus target price of $585.33.

Check Out Our Latest Stock Report on Synopsys

Insider Buying and Selling at Synopsys

In other Synopsys news, Director Robert G. Painter purchased 350 shares of Synopsys stock in a transaction that occurred on Thursday, September 11th. The shares were bought at an average price of $425.44 per share, for a total transaction of $148,904.00. Following the completion of the transaction, the director owned 2,291 shares of the company's stock, valued at approximately $974,683.04. This trade represents a 18.03% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, CFO Shelagh Glaser sold 3,655 shares of the company's stock in a transaction on Friday, September 5th. The shares were sold at an average price of $609.77, for a total transaction of $2,228,709.35. Following the sale, the chief financial officer directly owned 15,317 shares in the company, valued at approximately $9,339,847.09. The trade was a 19.27% decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 30,894 shares of company stock valued at $16,760,783. 0.62% of the stock is owned by company insiders.

Synopsys Stock Performance

NASDAQ SNPS opened at $487.76 on Monday. The company has a debt-to-equity ratio of 0.52, a current ratio of 1.62 and a quick ratio of 1.51. Synopsys, Inc. has a 1-year low of $365.74 and a 1-year high of $651.73. The business has a 50 day simple moving average of $571.71 and a two-hundred day simple moving average of $509.13. The stock has a market capitalization of $90.60 billion, a PE ratio of 38.29, a P/E/G ratio of 5.51 and a beta of 1.14.

About Synopsys

(Free Report)

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.

Read More

Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS - Free Report).

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Synopsys Right Now?

Before you consider Synopsys, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.

While Synopsys currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report
Like this article? Share it with a colleague.